Overview

Optimal Timing of Misoprostol Administration Prior to Office Hysteroscopy

Status:
Completed
Trial end date:
2015-12-01
Target enrollment:
0
Participant gender:
Female
Summary
The aim of this study was to determine whether misoprostol administered 12 hours before office hysteroscopy can relieve pain more effectively compared with misoprostol administered 3 hours before office hysteroscopy.
Phase:
Phase 2
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Cairo University
Treatments:
Misoprostol
Criteria
Inclusion Criteria:

- Nulliparous patients who have an indication for office hysteroscopy

Exclusion Criteria:

- Parous patients, menopausal patients and patients with cervical pathology, and
previous cervical surgery will be excluded from the study. Moreover, patients with
severe vaginal bleeding, acute pelvic inflammatory disease, glaucoma, allergy to
misoprostol, cardiac, liver or kidney diseases